THIRD PLENARY SESSION: ON THE ROAD TO ENHANCED COST-EFFECTIVENESS ANALYSIS: NEW DIRECTIONS, NEW MILESTONES
Author(s)
Freund D1, Basu A2, Griffin S3, Lakdawalla D4
1Claremont Graduate University, Claremont, CA, USA, 2University of Washington, Seattle, WA, USA, 3University of York, York, UK, 4School of Pharmacy and Sol Price School of Public Policy, University of Southern California, Los Angeles, CA, USA
Cost-per-QALY analysis was described by ISPOR’s Special Task Force on US Value Assessment Frameworks as “a starting point” to inform payer and policy-maker deliberations about health technologies. Recently, we have seen substantial progress and perhaps new milestones for more comprehensive value assessment in healthcare. This plenary will explore several innovative approaches to capturing patient and societal values that go beyond standard cost-per-QALY usage, with discussion of their underlying methods and their potential for use in decision making.
Conference/Value in Health Info
2020-05, ISPOR 2020, Orlando, FL, USA